LIQID Medical currently has two core devices under development. Each device has been designed to create the most clinically effective, cost-saving, and quality-of-life-improving solutions for severe and refractory glaucoma.

​

The OptiShunt fills a gap in the market for a highly effective glaucoma device which does not rely on the traditional subconjunctival drainage pathway.

​

The iFlow harnesses the traditional fluid drainage pathway, using innovative design to reduce surgical operating times, costs, and complications.